No.15, Lane 88 Wuwei Road, Putuo District, Shanghai
Tel: (+86) 021-50498986
Luo Chunyi（羅春憶）, is our executive Director and chief executive officer. Mr. Luo has extensive experience in corporate management and banking. Prior to joining the Group, he had served in Ping An Bank (formerly known as Shenzhen Development Bank) for 23 years since 1995. He held various senior positions in Ping An Bank, including the general manager of Haikou Haidian sub-branch and the assistant general manager of Haikou branch. He also worked as a manager in China Construction Bank from 1989 to 1995 before joining Ping An Bank. Mr. Luo graduated from the school of law of Hainan University (海南大學) in 2001. Mr. Luo obtained the qualification of economist (economic professional) in 1999 awarded by the Human Resource Office of Hainan province.
Steven Yang (楊悅文), is our chief operating officer. Mr Yang joined Pioneer-Pharma in 2016. He served as Product Manager,Marketing Manager during 2016-2019. Mr Yang was appointed as the General Manager of AW Department in October，2019. He is in charge of both marketing and sales of series of products of ALFASIGMA and NovaBay. Mr Yang was responsible for sales of CVM in Novartis and AstraZeneca. Mr Yang was majored in Pharmaceutical Chemistry with combined training mode and graduated from Shanghai State Institute Of Pharmaceutical Industry (which is renamed as China State Institute Of Pharmaceutical Industry )with a master’s degree in July，2013.
YU Yue (余悅), is our government affairs director. Ms. Yu joined our Group in October 2013 and was appointed as government affairs director, responsible for the Group’s government affairs and government relation management. Ms. Yu graduated from Dongbei University of Finance and Economics with a bachelor’s degree in management in September 2004, and with a master’s degree in enterprise management in January 2007.
XUE Yi (薛毅), is our chief financial officer. Mr. Xue joined the Group in January 2002 and served as the manager of the audit department of Pioneer Pharma between January 2002 and January 2003, and was appointed as the manager of the finance department of Pioneer Pharma since February 2003. Mr. Xue was appointed as the Company’s deputy financial officer since February 2015, responsible for assisting chief financial officer with finance and accounting management, and was appointed as chief financial officer in December 2016. Mr. Xue is also the executive director of the Company’s wholly-owned subsidiary Naqu Area Pioneer Pharma Co., Ltd. Mr. Xue has over 21 years of experience in the accounting and auditing field. Prior to joining the Group, Mr. Xue worked at Sichuan Dazhou Foods Company (四川省達州市食品公司). Mr. Xue obtained a bachelor’s degree in accounting from Southwestern University of Finance and Economics in June 1997, and obtained the qualification of Medium Level Accountant in August 2000.
YANG Xiuyan (楊秀顏), is our general manager of Polichem business unit. Ms. Yang joined our Group in December 1998 and worked as the manager for Shandong and Northern China area between 1998 and 2012. She was appointed as our deputy general manager and sales director in January 2013 and was responsible for the sales and marketing of our Group, in particular in the Northern Yangtze River area. In September 2014, Ms. Yang was promoted as a general manager of AW (Alfa Wassermann) Business Unit, and is responsible for the promotion and sales of AW’s products of our Group. In November 2015, Ms. Yang was appointed as the general manager of Polichem Business Unit, and is responsible for the promotion and sales of Polichem’s products of the Group. She has nearly 20 years working experience in the pharmaceutical industry. Prior to joining our Group, Ms. Yang worked at Boli People’s Hospital of Heilongjiang Province (黑龍江省勃利人民醫院). Ms. Yang was awarded with a bachelor’s degree in clinical medicine by the Binzhou Medical University (濱州醫學院) in July 1986.
WANG Rongrong (王榮榮), is our general manager of Alcon business unit and national director of commerce department. Ms. Wang joined our Group in July 2004, and worked as a manager of commerce department from September 2006 to August 2014. In September 2014, Ms. Wang was promoted as our national director of commerce department, mainly responsible for bidding, pricing, receivables management and channel management and other business related work. Ms. Wang was appointed as our general manager of Alcon business unit in January 2016, mainly responsible for co-promotion and channel management of Alcon’s products of the Group. Ms. Wang has more than 19 years of working experience in pharmaceutical industry. Prior to joining the Group, Ms. Wang worked in Hainan Sanye Pharmaceutical Group (海南三葉醫藥集團). Ms. Wang received a bachelor’s degree in biological engineering in June 2000, and a licensed pharmacist qualification certificate in 2005.
HUANG Wenfei (黃文斐), is our general manager of ophthalmology business unit. Ms. Huang joined our Group in 1998 and worked as a manager of our commerce department between 1998 and 2004 and a sales director in 2004. She was appointed as our deputy general manager in October 2004 and a director of Pioneer Pharma in April 2011, responsible for various aspects of our business, including human resources, administration, product registration, purchase, logistics, product quality, commerce and government affairs. In September 2014, Ms. Huang was promoted as a general manager of our ophthalmology business unit, responsible for the promotion and sales of all the ophthalmic medical devices products of our Group. Ms. Huang has nearly 24 years of working experience in the pharmaceutical industry. Prior to joining our Group, she worked at Shanghai Xudong Haipu Pharmaceutical Co., Ltd. (上海旭東海普藥 業有限公司) and Shanghai Eighteenth Pharmaceutical (上海第十八製藥廠). Ms. Huang obtained an executive master’s degree in business administration by Tongji University (同濟大學) in March 2009.
Fu Tung (富冬), is our general manager of medical device business unit. Mr. Fu joined Pioneer in May of 2019 and take the general manager for Medical Device Department of Pioneer. I was service for orthopedic‘s implants of joints in the field to over 35 years and in charge of R&D, production and management. Worked for some companies of Jardine Danby, J&J (China), Smith&Nephew, Fosun Pharmacy, Beijing Plus orthopedic Co.Ltd., WeiGao Orthopedics Co. Ltd., Taiwan Unite and so on. Graduated from Kunming Medical College in 1984.
Fred Zhang (張權), is the general manager of our Dental Business division. Mr. Zhang started cooperation as a consultant of the business division in March 2020, and formally joined the Dental Business Division in March 2021 as the regional sales manager. He was appointed as the General Manager of the Dental Business Division of the Group on August 30, 2021. In charge of the marketing and sales of the group's dental division's agent of Ivoclar Vivadent Zenostar (WIELAND Zenostar) and Korea's DMAX series zirconia products. Mr. Zhang has been working as marketing director for Dentsply Dental (Tianjin) Trading Co., LTD in 1994, Sirona Dental Systems (Shanghai) Trading Co., LTD in 2005, and as technical sales director for Ivoclar Vivadent (Shanghai) Trading Co., LTD in 2014. He has nearly 30 years of marketing sales experience in dental business . Mr. Zhang graduated from Beijing Institute of Civil Engineering and Architecture with a major in industrial and Civil Architecture in June 1986.
Zhang Bin (張斌), is the general manager of Reproductive Health BU. The establishment of Reproductive Health BU in December, 2021 announced Pioneer’s formal entry into Assisted Reproduction field. Mr. Zhang has 22 years working experience includes 16 years in assisted reproduction field. He joined Pioneer Group in 2022, previously worked for provincial FDA、Sales and Marketing Department of several large domestic and global pharmacy enterprises including Bristol-Myers Squibb，Novo Nordisk，MSD，FERRING，GENSCI. Mr. Zhang graduated in Pharmacy Administration from China Pharmaceutical University in 2001..
Niu Kai (牛凱), is the general manager of Broad Marketing BU. He joined Pioneer Group in 2009 and worked as OTC manager (Beijing) from 2012 to 2016, in charge of sales affairs for relevant products in Beijing and Tianjing area from 2016 to 2021. Mr. Niu was accredited general manager of Broad Marketing BU in 2022, responsible for sales promotion in basic (country) market. Mr. Niu graduated in Western medicine from the Open University of China and owns nearly 20 years working experience in pharmaceuticals industry.
Liu Xuefeng (劉雪峰), is our BD Director. Mr. Liu joined Pioneer Group in September 2008 and was designated BD Director in April 2012, mainly in charge of purchasing new products and exploiting commercial opportunity. Mr. Liu has over 11 years working experience in pharmaceuticals industry, he worked for AstraZeneca (Wu Xi) as sales representative from January to August 2008 in charge of promoting medical treatment and medicine knowledge. Mr. Liu serves as the assistant secretary-general and head of International Committee of CSBMB from July 2005. Mr. Liu worked for HUADONG MEDICINE (Hangzhou) from August 1999 to September 2002. Mr. Liu acquired Bachelor's Degree of Biopharmaceutics awarded by China Pharmaceutical University and acquired Master’s Degree of Microbial and biochemical pharmacy awarded by Shanghai Institute of Pharmaceutical Industry in July 2005.
Tianshu Zhou (周天舒), is the sales director of our Pioneer-Bio Technology Company. Ms. Zhou joined the Group in 2020 and served as the Marketing Specialist of the Ophthalmology Division. In December 2020, she was appointed as the Sales Director of the Pioneer-Bio Technology Company of the Group, and do the management and operation of it . Ms. Zhou obtained a bachelor’s degree in accounting from Adelphi University, New York, USA in 2016. Before joining the Group, Ms. Zhou worked in Jones Lang LaSalle (JLL) in charge of general ledger accounting in the Asia-Pacific region.